Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy

The purpose of this study is to verify that the incidence rate of urinary tract infections after a routine outpatient cystoscopy is the same for non-sterile (clean) and sterile procedural techniques.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Urinary Tract Infections Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Infections Male Urogenital Diseases Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

VAMC Minneapolis

Minneapolis, Minnesota, 55417, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 years of age or older
Patients undergoing routine outpatient flexible cystoscopy

Exclusion criteria

Patients who have had a urinary tract infection within 3 months prior to flexible cystoscopy
Patients with an indwelling catheter

Treatment and study plan

clean patient preparation for cystoscopy

Procedure

sterile patient preparation for cystoscopy

Procedure

Primary outcomes

To verify that the incidence rate of urinary tract infections after a routine outpatient cystoscopy is the same for non-sterile (clean) and sterile procedural techniques

Sponsors and collaborators

Lead sponsor

University of Minnesota

Other

Registry information

Important dates

Study start: 2005
Study completion: 2007
First posted: Sep 15, 2005
Registry last updated: Feb 4, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed